Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ)

PRESS RELEASE

published on 09/09/2025 at 11:30, 10 months 21 days ago

Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
Berenberg initiates coverage on Eckert & Ziegler SE with a "Buy" recommendation and €24 price target, highlighting market position and rising demand for radioisotopes in nuclear medicine

Buy Recommendation Eckert & Ziegler SE Nuclear Medicine Berenberg Radioisotopes
BRIEF

published on 08/08/2025 at 07:50, 11 months 23 days ago

Eckert & Ziegler Reports Earnings Growth in First Half of 2025

Financial Results Profit Growth Medical Segment Isotope Products 2025 Forecast
PRESS RELEASE

published on 08/08/2025 at 07:45, 11 months 23 days ago

Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025
Eckert & Ziegler SE reports a further increase in earnings in the first half of 2025, with sales of €148.8 million and net income of €21.4 million. Confirmed forecast for 2025: sales around €320 million and EBIT around €78 million

Sales Increase Earnings Eckert & Ziegler SE Medical Segment 2025 Forecast
BRIEF

published on 08/05/2025 at 11:55, 11 months 25 days ago

Eckert & Ziegler Announces Share Split Effective August 2025

Liquidity Frankfurt Stock Exchange Share Split Nuclear Medicine Bonus Shares
PRESS RELEASE

published on 08/05/2025 at 11:50, 11 months 25 days ago

Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
Eckert & Ziegler SE implements share split, issuing bonus shares effective August 15, 2025, tripling tradable shares for improved liquidity without changing shareholder percentages

Liquidity Share Split Dividend Rights Eckert & Ziegler SE Bonus Shares
BRIEF

published on 07/29/2025 at 14:05, 1 year ago

Eckert & Ziegler Chosen for Manufacturing Archeus’ ART-101 Radiopharmaceutical

Clinical Trial Manufacturing Agreement Radiopharmaceuticals Prostate Cancer ART-101
PRESS RELEASE

published on 07/29/2025 at 14:00, 1 year ago

Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA

Eckert & Ziegler Prostate Cancer Radiopharmaceutical ART-101 Archeus
BRIEF

published on 07/28/2025 at 14:35, 1 year ago

Eckert & Ziegler Completes Capital Increase, Prepares Share Split

Liquidity Eckert & Ziegler Capital Increase Share Split Nuclear Medicine
PRESS RELEASE

published on 07/28/2025 at 14:30, 1 year ago

Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
Eckert & Ziegler SE increases capital and prepares for share split, aiming to enhance share liquidity and trading. Leading in isotope-related components for nuclear medicine and radiation therapy

Liquidity Eckert & Ziegler Capital Increase Share Split Isotope-related Components
BRIEF

published on 07/15/2025 at 14:05, 1 year ago

Eckert & Ziegler's Training Program Recognized for Excellence

Training Excellence Berlin Chamber Award Trainee Retention Career Prospects Future Applications

Published on 07/31/2026 at 08:00, 7 minutes ago

Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 07/31/2026 at 01:39, 6 hours 28 minutes ago

Transition from OTCQB to Unsponsored OTC Quotation
Published on 07/30/2026 at 23:45, 8 hours 22 minutes ago

Namibia Critical Metals Announces Completion of Japan's C$23 Million Earn-In and Formation of Strategic Joint Venture Company for the Lofdal Heavy Rare Earth Project
Published on 07/30/2026 at 23:01, 9 hours 6 minutes ago

Pinetree Capital Announces Unaudited Financial Results for the Period Ended June 30, 2026 and Management Changes
Published on 07/30/2026 at 23:00, 9 hours 7 minutes ago

Eagle Plains Announces Approval of Warrant Expiry Extension

View all ACCESSWIRE

Published on 07/31/2026 at 07:30, 36 minutes ago

SURTECO GROUP SE: Sales and earnings within the target corridor; rise in adjusted and reported EBITDA; forecast confirmed
Published on 07/31/2026 at 07:30, 37 minutes ago

R. STAHL publishes half-year results – Sales and profitability in line with planning – Forecast for 2026 confirmed
Published on 07/31/2026 at 07:29, 37 minutes ago

RBI: Semi-Annual Financial Report 2026 - Consolidated profit (excl. Russia) up 25%
Published on 07/31/2026 at 07:25, 41 minutes ago

EQS-Adhoc: UBS AG: UBS AG published its 2Q26 financial report
Published on 07/31/2026 at 07:00, 1 hour 6 minutes ago

Medacta Group SA: Medacta reports continued above-market revenue growth of 9.7% in c.c. in H1 2026

View all EQS

Published on 07/31/2026 at 07:45, 22 minutes ago

2026 First-Half financial report
Published on 07/31/2026 at 07:00, 1 hour 6 minutes ago

AXA - Half Year 2026 Earnings
Published on 07/30/2026 at 18:15, 13 hours 51 minutes ago

Publication of the 2026 half-year financial report
Published on 07/30/2026 at 18:01, 14 hours 5 minutes ago

First-half 2026 results
Published on 07/30/2026 at 18:00, 14 hours 7 minutes ago

PR ICADE – ACQUISITION OF A CONTROLLING INTEREST IN COMET

View all LES ECHOS COMFI WIRE

News